As the UK approaches the end of 2020 without clarity over future trading arrangements with the EU, at the same time as newly-imposed travel restrictions put further pressure on the supply chain, the country’s generics industry is nevertheless not expected to suffer major disruptions, according to the British Generic Manufacturers Association.
UK Turbulence Not Expected To Disrupt Supply
No ‘Major Disruption’ Anticipated Despite Brexit Cliff And Freight Restrictions
Despite Brexit uncertainty and travel restrictions that have just been imposed on the UK, the country’s generics industry is not expected to suffer major disruptions.
